Atara Biotherapeutics, Inc 10-K for FY2025
Atara Biotherapeutics, Inc. (ATRA)
10-K
2026-03-16
For: 2025-12-31
View Original
Added on
April 11, 2026
About this 10-K
Atara Biotherapeutics, Inc filed this 10-K on March 16, 2026, covering the fiscal year ended December 31, 2025 (FY2025).
Headline figures
Fiscal year ended December 31, 2025, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $120.77M
- down 6.3% from $128.94M a year earlier
- Net income
- $32.69M
- compared with a net loss of $85.4M a year earlier
- Diluted EPS
- $2.57
- compared with -$11.41 a year earlier